| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 11/25/2004 | US20040234634 Pharmaceutical compositions having appetite suppressant activity |
| 11/24/2004 | EP1478340A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 11/18/2004 | WO2004098538A2 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 11/18/2004 | US20040228935 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 11/18/2004 | CA2518506A1 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 11/17/2004 | CN1176101C Compound (I), method for extracting it and pharmaceutical composition containing it |
| 11/11/2004 | US20040225139 a 3-oxo-androstrane carbothioic acid compound |
| 11/11/2004 | US20040224934 3 -oxo-androstrane carbothioic acid compound |
| 11/11/2004 | US20040224932 crystal structure; antiinflammatory agents; antiallergens |
| 11/11/2004 | US20040224931 3-oxo-androstrane carbothioic acid compound |
| 11/04/2004 | US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/04/2004 | US20040220157 a 3-oxoandrostrane carbothioic acid compound |
| 11/04/2004 | US20040220156 Novel anti-inflammatory androstane derivative compositions |
| 11/03/2004 | EP1472272A1 Crystalline complexes of fluticasone 2-furoate |
| 11/03/2004 | EP1471900A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 11/03/2004 | EP1471896A1 Formulations for inhalation |
| 11/03/2004 | EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 10/28/2004 | WO2004092329A2 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 10/28/2004 | CA2522213A1 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 10/20/2004 | CN1537863A Herminium's triochistisaponine extract and its extraction refining method and its medical use |
| 10/07/2004 | US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy |
| 09/30/2004 | DE19681353B4 Ginsenoside Mc, an intestinal flora metabolite of ginseng saponin |
| 09/29/2004 | CN1531967A Use of mometasone furoate for treating airway nassage and lung diseases |
| 09/29/2004 | CN1531928A Panaxitriol saponin preparation with biological activity and use |
| 09/15/2004 | EP1341801B1 A process for isolating saponins from soybean-derived materials |
| 09/15/2004 | EP0680327B1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 09/15/2004 | CN1528780A Process for extracting total saponin of American ginseng and powder injection thereof |
| 09/15/2004 | CN1166679C Method for extracting and separating notoginsenoside R1, panaxcoside Re, pseudo-ginseng element from pseudo-ginseng crude powder |
| 09/08/2004 | EP1453495A2 Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 09/08/2004 | EP0873131B1 Processes for preparation of rg3 and rg5 ginsenosides |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 08/24/2004 | US6780853 For modulating brain excitability |
| 08/19/2004 | US20040162425 6,7-Oxygenated steroids and uses related thereto |
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/17/2004 | US6777400 Anti-inflammatory androstane derivative compositions |
| 08/17/2004 | US6777399 Anti-inflammatory androstane derivative compositions |
| 08/12/2004 | US20040157814 6, 7-Oxygenated steroids and uses related thereto |
| 08/12/2004 | US20040157810 Corticosteroid conjugates and uses thereof |
| 08/11/2004 | EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 08/11/2004 | CN1161370C Method for preparing quasi-ginsenoside P11 |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 08/10/2004 | CA2092621C Stabilizer for phospholipid vesicles |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/15/2004 | WO2004058796A1 Promoter for the production of hyaluronic acid containing ginsenoside compound k |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 06/30/2004 | CN1509177A Method for treating dry eye disorders |
| 06/30/2004 | CN1155386C Nailpolish having function of resisting psoriasis |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/15/2004 | US6750210 Formulation containing novel anti-inflammatory androstane derivative |
| 06/09/2004 | EP1426352A2 Intermediates for the sythesis of vitamin D and steroid derivatives |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 05/27/2004 | US20040101932 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/19/2004 | EP1420026A2 Use of conjugates of phytosterol or phytostanol with ascorbic acid in treating or preventing cardiovascular disease, and compositions thereof |
| 05/12/2004 | CN1149222C Preparation of furoic acid momisone |
| 05/06/2004 | WO2003104254A3 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/06/2004 | EP1414843A1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/21/2004 | CN1491230A Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/21/2004 | CN1490326A Triterpenoid saponin in stem and leaf of American ginseng and its medicinal use and preparation |
| 04/15/2004 | US20040071645 Glucocorticoid formulation; penetration, bioavailability |
| 04/08/2004 | WO2004028475A2 Glycosylceramide analogues |
| 04/08/2004 | CA2500478A1 Glycosylceramide analogues |
| 03/25/2004 | WO2004024745A2 Complexes of 6.alpha. 9.alpha. - difluoro - 17. alpha. - [ (2 - furanylcarbonyl) oxy] - 11.beta. -hydroxy - 16- .alpha. -methyl - 3oxo- androsta- 1,4 -diene - 17 .beta. -carbothioic acid s-fluoromethyl ester |
| 03/17/2004 | CN1482136A Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/04/2004 | WO2004017904A2 Corticosteroid conjugates and uses thereof |
| 03/04/2004 | WO2003043640A3 Treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 03/04/2004 | US20040043974 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease |
| 03/03/2004 | EP1392322A1 Method of treating dry eye disorders |
| 03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/11/2004 | CN1473841A High yield environmental protection type industrial separating method for ginseng saponin Rb1 |
| 02/05/2004 | US20040023936 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 01/29/2004 | WO2004009613A1 Anti-inflammatory or anti-allergic androstane complexes |
| 01/28/2004 | CN1470519A Rhizoma alismatis total triterpene alcohol extract and its preparation method |
| 01/22/2004 | US20040014735 11-Beta substituted 19-nor-17-alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 01/15/2004 | WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 01/14/2004 | CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/14/2004 | CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/07/2004 | CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/01/2004 | US20040002484 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/30/2003 | US6670459 From Asparagus racemosus; potent immunomodulatory agent; solvent extraction |
| 12/30/2003 | US6670348 Antitumor geldanamycins |
| 12/18/2003 | WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 12/18/2003 | US20030232797 Useful as immunomodulating and antiinflammatory compounds and in treatment of cardiovascular disease and cancer |
| 12/18/2003 | US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 12/18/2003 | CA2488618A1 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 12/17/2003 | CN1131237C Usage of steroi saponin for preventing and curing senile dementia and new steroi saponin |
| 12/11/2003 | US20030229059 Hormone inhibitors; anticancer agents |
| 12/10/2003 | EP0671924B1 Digitalis-like compounds |
| 12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
| 12/02/2003 | US6656917 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 11/20/2003 | US20030216328 Androgen derivatives and uses thereof |
| 11/18/2003 | US6649745 Oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanoside |
| 11/11/2003 | US6645955 3,6-dihydroxy-24-amidyl steroid derivatives |